Drug Recall Reasons
Why are drugs recalled? The most common FDA drug recall reasons — from manufacturing defects to contamination and labeling errors.
Every FDA drug recall includes a reason — a description of the quality or safety issue that triggered the enforcement action. Unlike food recalls (where bacterial contamination and allergens dominate), drug recalls are more commonly driven by manufacturing quality issues such as cGMP deviations, impurities, and sterility concerns. Understanding the reason for a recall helps determine how serious the health risk is for patients who may have taken the affected product.
Most Common Recall Reasons
FDA drug recalls categorized by reason type, sorted by frequency.
| # | Reason Category | Recalls | % of Total | Search |
|---|---|---|---|---|
| 1 | Lack of Sterility Assurance | 5,350 | 30.5% | Search |
| 2 | cGMP Deviations | 3,888 | 22.2% | Search |
| 3 | Contamination | 2,126 | 12.1% | Search |
| 4 | Other | 1,853 | 10.6% | — |
| 5 | Labeling Errors | 1,433 | 8.2% | Search |
| 6 | Impurities / Nitrosamines | 696 | 4% | Search |
| 7 | Foreign Particles | 659 | 3.8% | Search |
| 8 | Potency Issues | 584 | 3.3% | Search |
| 9 | Stability / Out of Spec | 551 | 3.1% | Search |
| 10 | Failed Dissolution | 389 | 2.2% | Search |
| 11 | Cross-Contamination / Mix-up | 10 | 0.1% | Search |
Categories are derived from recall reason text using keyword matching. Percentages are based on total recall records in the database.
Common Drug Recall Reasons Explained
cGMP (Current Good Manufacturing Practice) Deviations
cGMP regulations are the FDA's minimum standards for the methods, facilities, and controls used in manufacturing, processing, and packing drugs. When a facility fails to follow these regulations — whether through inadequate environmental monitoring, equipment failures, documentation gaps, or process deviations — the FDA may classify the issue as a cGMP violation triggering a recall. cGMP-based recalls are the most common type of drug recall and often do not involve direct patient harm; instead, they reflect quality system failures that could potentially lead to a product defect. These are often Class II or Class III recalls.
Impurities and Nitrosamines
Nitrosamine impurities became a major drug safety issue starting in 2018 when NDMA (N-nitrosodimethylamine) was discovered in certain blood pressure medications (valsartan, losartan). Nitrosamines are probable human carcinogens — they don't cause immediate harm, but long-term exposure above certain thresholds may increase cancer risk. Since 2018, the FDA has expanded testing requirements and recalls have been issued across multiple drug classes including ranitidine (Zantac), metformin, and others. Any drug containing nitrosamine impurities above acceptable daily intake limits triggers a recall.
Sterility and Contamination
Injectable drugs, eye drops, and other sterile products must be free of microbial contamination. When routine sterility testing fails, or when environmental monitoring detects contamination in a sterile manufacturing environment, a recall is typically required. These recalls are taken extremely seriously because contaminated sterile drugs can cause serious infections, including life-threatening sepsis. Sterility failures in injectable drugs often result in Class I recalls — the most serious classification. Microbial contamination in non-sterile oral drugs is less immediately life-threatening but still triggers recalls based on the level of contamination detected.
Potency and Dissolution Failures
Drug products must contain the labeled amount of active ingredient within specified tolerances. If testing reveals that a product is superpotent (contains more active ingredient than labeled) or subpotent (less than labeled), a recall is required. Superpotency can cause overdose effects; subpotency means the drug may be ineffective. Failed dissolution testing indicates that a tablet or capsule is not releasing its active ingredient at the rate specified — which can affect how the drug is absorbed and its therapeutic efficacy. These recalls are typically Class II, reflecting potential health impact without immediate serious harm.
Labeling Errors
Drug labeling recalls occur when the label does not accurately represent the product. This includes wrong drug name, incorrect dosage instructions, missing contraindications or warnings, or one drug packaged with another drug's label — which is particularly dangerous in look-alike products. Mix-up recalls (where two different products are accidentally swapped during packaging) can be extremely serious if patients receive a drug with a completely different mechanism and dosage requirement. Labeling recalls range from Class I (dangerous mix-ups) to Class III (minor technical errors with no health impact).
Frequently Asked Questions
Mix-up and cross-contamination recalls — where patients could receive the wrong drug entirely — are generally considered the most acutely dangerous. A patient taking a blood thinner who receives an anticoagulant at the wrong dose, or someone with a known allergy who receives a mislabeled product, faces immediate serious risk. Contamination of sterile injectable products is also extremely serious due to the risk of sepsis and meningitis. For long-term risk, nitrosamine impurities are concerning because they are probable carcinogens, though the risk is based on cumulative exposure rather than a single dose.
It depends on the reason for recall and the classification. For Class I recalls involving serious health risks, stop using the product immediately and contact your prescribing doctor or pharmacist. For many Class II recalls (including most nitrosamine recalls), the FDA may recommend continuing the medication until a replacement is available, because the risk of stopping treatment (for conditions like high blood pressure, diabetes, or depression) may outweigh the small additional risk from the impurity. Never stop a prescription medication without consulting your healthcare provider first.
Drug recalls are more frequently driven by manufacturing quality issues (cGMP failures, impurities, potency) rather than the biological contamination (Salmonella, Listeria) that dominates food recalls. Drug manufacturing is also more tightly regulated — every batch must be tested before release, and any deviation from specifications triggers an investigation. This means many drug recalls are caught during manufacturing quality checks before the product causes harm, while food recalls may be triggered by illness outbreaks or consumer complaints after the product has already been distributed and consumed.
Generic drugs appear in FDA recall data more frequently than brand-name drugs, primarily because generics vastly outnumber branded products in the U.S. market — generics account for about 90% of all prescriptions filled. Per-product, recall rates are similar between generic and branded manufacturers. Many large generic drug manufacturers also produce high volumes across many facilities, increasing their statistical exposure. Quality standards for generic drugs are identical to those for branded drugs under FDA regulations.
Search Drug Recalls
Look up recalls by drug name, firm, classification, or reason using our full FDA enforcement database.